Genetic diagnosis of pancreatic cancer

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 9, Issue 1, 2002, Pages 39-44

  Mizumoto, Kazuhiro ^a   Tanaka, Masao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Centrosome; K ras; p53; Pancreatic cancer; Telomerase

Indexed keywords

PROTEIN P53; TELOMERASE;

ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PATIENT; CENTROSOME; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EARLY DIAGNOSIS; ENZYME ACTIVITY; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; ONCOGENE K RAS; PANCREAS ADENOMA; PANCREAS CANCER; PANCREAS CARCINOMA; PANCREAS JUICE; PANCREATITIS; SENSITIVITY AND SPECIFICITY;

CENTROSOME; GENES, RAS; HUMANS; PANCREATIC JUICE; PANCREATIC NEOPLASMS; POINT MUTATION; TELOMERASE; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036248219     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340200003     Document Type: Article

References (42)

1. Molecular diagnosis of pancreas carcinoma
2. Molecular oncology in pancreatic cancer
3. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
4. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinomas
5. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma
6. Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours
7. Analysis of Ki-ras codon 12 mutations in the duodenal juice of patients with pancreatic cancer
8. K-ras mutations in the duodenal fluid of patients with pancreatic carcinoma
9. Diagnostic utility of K-ras mutations in fine-needle aspirates of pancreatic masses
10. Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation
11. Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice
12. Detection of K-ras point mutations at codon 12 in pure pancreatic juice for the diagnosis of pancreatic cancer by PCR-RFLP analysis
13. Detection of K-ras point mutations at codon 12 in pancreatic juice for the diagnosis of pancreatic cancer by hybridization of protection assay: A simple method for the determination of the type of point mutations
14. Detection of K-ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas
15. Long-term follow-up of patients with chronic pancreatitis and K-ras gene mutation detected in pancreatic juice
16. Quantitative analysis of ras gene mutation in pancreatic juice for diagnosis of pancreatic adenocarcinoma
17. Quantitative determination of K-ras mutations in pancreatic juice for diagnosis of pancreatic cancer using hybridization protection assay
18. Molecular markers for diagnostic cyotology of neoplasms in the head region of the pancreas: Mutation of K-ras and overexpression of the p53 protein product
19. Pancreatic adenocarcinomas frequently show p53 gene mutations
20. Overexpression of p53 protein in adenocarcinoma of the pancreas
21. p53 protein expression as prognostic factor in human pancreatic cancer
22. Immuunocyotochemical detection of p53 protein from pancreatic duct brushings in patients with pancreatic carcinoma
23. Immunocytochemical detection of p53 protein as an adjunct in cytologic diagnosis from pancreatic duct brushings in mucin-producing tumors of the pancreas
24. The establishment of a preoperative diagnosis of pancreatic carcinoma using cell specimens from pancreatic duct brushing with special attention to p53 mutations
25. Structure and function of telomerase
26. Telomere shortening may contribute to aging and cancer: A perspective
27. Specific association of human telomerase activity with immortal cells and cancer
28. Semi-quantitative analysis of telomerase in pancreatic ductal adenocarcinoma
29. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states
30. Telomerase activity is detected in pancreatic cancer but not in benign tumors
31. Increased telomerase activities in human pancreatic duct adenocarcinoma
32. Shortened telomere length and increased telomerase activity in hamster pancreatic duct adenocarcinomas and cell lines
33. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis
34. Telomerase activity for the preoperative diagnosis of pancreatic cancer
35. Telomerase activity detected in pancreatic juice 19 months before a tumor is detected in a patient with pancreatic cancer
36. Stricture of the main pancreatic duct due to focal pancreatitis coexistent with pancreatic cystadenoma
37. Activation of telomerase and its diagnostic application in biopsy specimens from biliary tract neoplasms
38. Quantitative analysis of hTERT mRNA expression in colorectal cancer
39. Immunohistochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections
40. Centrosome defects and genetic instability in malignant tumors
41. Centrosome abnormalities in pancreatic ductal carcinoma
42. 9-Hydroxyellipticine inhibits telomerase activity in human pancreatic cancer cells